Professor Sandawana William Majoni

Honorary clinical fellow

Qualifications:

PhD Candidate, CDU/MSHR, 2018-2026; Fellow, Royal College of Physicians (FRCP), London, 2019; Master of Clinical Medicine (Leadership & Management) (MCLAM), University of Newcastle, 2018; Master of Biostatistics (MMedStats), University of Newcastle and Biostatistics Collaboration Australia BCA), 2015; Fellow, Royal Australasian College of Physicians (FRACP), 2011; United Kingdom Certificate of Completion of Specialist Training (UKCCST): Nephrology and General Medicine, 2009; Member, Royal College of Physicians (MRCP), London and UK, 2000; Bachelor of Medicine and Bachelor of Surgery (MBChB), University of Zimbabwe School of Medicine, 1994

Location:

Darwin - Royal Darwin Hospital

Biography:

After studying medicine in Zimbabwe, Professor Majoni completed specialist training in Nephrology and Internal Medicine in the UK and Australia and biostatistics training with the University of Newcastle and Biostatistics Collaboration Australia. He completed a two-year Clinical Research Fellowship with the University of Oxford’s prestigious Clinical Trial Service Unit and Epidemiological Studies Unit (CTSU). 

He is a senior staff specialist at the Royal Darwin Hospital, former clinical dean for the Flinders University Northern Territory Medical Program and has headed the Department of Nephrology and the Renal Transplantation service within the hospital. Among several projects, he has led and collaborated on observational and cohort studies.

He has extensive experience in large scale clinical trials (RCT’s) and systematic reviews with several publications in this area.

Professor Majoni collaborates with researchers across Australia and internationally, covering all areas of nephrology, diabetes, and cardiovascular disease.

His work includes RCTs in renal disease such as the Study of Heart and Renal Protection (SHARP) and several other RCTs from the CTSU and the INFERR clinical trial. Current collaboration includes projects addressing Acute Kidney Injury (AKI), dialysis models of care, renal anaemia, mental health and wellbeing in patients with CKD, effective and culturally safe communication with First Nations Australians requiring Hospital and health services, kidney transplantation and infectious diseases in people with CKD. He is on the steering committee for several collaborative projects.

 

Professor Sandawana William Majoni
Email
Research Themes
  1. eGFR Study News - 2020 Annual Report

    eGFR Study News - 2020 Annual Report

    Date

    In this edition of eGFR Study News, we highlight key activities during 2020.

  2. Indigenous Australians travelling 1000 kilometres for kidney dialysis: report

    Indigenous Australians travelling 1000 kilometres for kidney dialysis: report

    Date

    In a new Menzies School of Health Research report, patients and carers from across northern and central Australia called on state, territory and federal government health ministers to overhaul the system to provide more holistic care.

  3. Indigenous kidney patients call for equitable care in new report

    Indigenous kidney patients call for equitable care in new report

    Date

    Indigenous people with kidney disease living in remote and rural Australia as well as their support networks have made a resounding call for equitable health care closer to home in a report released today by Menzies School of Health Research.

1. Rohatgi, R., Ross, M.J.,Majoni, S.W., (2017) Telenephrology: current perspectives and future directions  Kidney International, in press.
2. Hughes, J.T., Barzi, F., Hoy, W.E., Jones, G.R.D., Rathnayake, G., Majoni, S.W., et al, (2017) Bilirubin concentration is positively associated with haemoglobin concentration and inversely associated with albumin to creatinine ratio among Indigenous Australians: eGFR Study. Clin Biochem.  pii: S0009-9120(17)30349-1. doi: 10.1016/j.clinbiochem.2017.08.011. 
3. Gorham, G., Howard, K., Togni, S., Lawton, P., Hughes, J., Majoni, S.W., et al, (2017) Economic and quality of care evaluation of dialysis service models in remote Australia: protocol for a mixed methods study. BMC Health Serv Res.17(1):320. doi: 10.1186/s12913-017-2273- 5. 
4. Dennis, J., Majoni, W., Tinsley, J., Kangaharan, N., (2017) Safety and Efficacy of Warfarin Therapy in Remote Communities of the Top End of Northern Australia, Heart Lung Circ. pii: S1443-9506(17)30066-5. doi: 10.1016/j.hlc.2017.01.004. 
5. Majoni, S.W., Lawton, P.D., Barzi, F., Cass, A., Hughes, J.T., (2017) Assessing the Association between Serum Ferritin, Transferrin Saturation, and C-Reactive Protein in Northern Territory Indigenous Australian Patients with High Serum Ferritin on Maintenance Haemodialysis. Int J Nephrol. 2017:5490963. doi: 10.1155/2017/5490963. 
6. Barr, E.L., Maple-Brown, L.J., Barzi, F., Hughes, J.T., Jerums, G., Majoni, S.W., et al. (2017) Comparison of creatinine and cystatin C based eGFR in the estimation of glomerular filtration rate in Indigenous Australians: The eGFR Study. Clin Biochem. 50(6):301-308. doi: 10.1016/j.clinbiochem.2016.11.024.
7. Ramanathan, G., Abeyaratne, A., Sundaram, M., Fernandes, D.K., Pawar, B., Majoni, S.W., et al (2017) Analysis of clinical presentation, pathological spectra, treatment  and outcomes of biopsy-proven acute post infectious glomerulonephritis in adult indigenous people of the Northern Territory of Australia. Nephrology (Carlton).22(5):403-411. doi: 10.1111/nep.12797. 
8. Iyngkaran, P., Majoni, W., Cass, A., Sanders, P., Ronco, C., Brady, S., et al. (2015) Northern Territory perspectives on heart failure with comorbidities – understanding trial validity and exploring collaborative opportunities to broaden the evidence base,  Heart Lung Circ. 24(6):536-43. doi: 10.1016/j.hlc.2014.12.007. 
9. Chalmers, R.M., Majoni, S.W., Ward, L., Perry, G.J., Jabbar, Z., Currie, B.J. (2014) Melioidosis and end-stage renal disease in tropical northern Australia,  Kidney Int. 86(5):867-70. doi: 10.1038/ki.2014.228. 
10. Majoni, S.W., Ellis, J.A., Hall, H., Abeyaratne, A., Lawton, P.D. (2014) Inflammation, high ferritin, and erythropoietin resistance in indigenous maintenance hemodialysis patients from the Top End of Northern Australia,  Hemodial Int. 18(4):740-50. doi: 10.1111/hdi.12173.